Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
462.40M | 508.00M | 448.83M | 374.61M | 373.82M | Gross Profit |
349.41M | 386.62M | 348.35M | 306.06M | 297.46M | EBIT |
306.38M | 344.41M | 358.42M | 357.01M | 392.35M | EBITDA |
-168.34M | -263.91M | 359.82M | 358.40M | 393.93M | Net Income Common Stockholders |
-299.76M | -347.69M | 125.63M | 611.84M | 314.36M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
51.25M | 72.03M | 87.99M | 62.70M | 144.11M | Total Assets |
6.05B | 7.63B | 8.51B | 7.06B | 5.85B | Total Debt |
3.01B | 3.92B | 3.68B | 2.94B | 2.79B | Net Debt |
2.96B | 3.85B | 3.59B | 2.88B | 2.64B | Total Liabilities |
3.47B | 4.54B | 4.77B | 3.54B | 3.31B | Stockholders Equity |
1.56B | 1.99B | 2.46B | 2.39B | 1.64B |
Cash Flow | Free Cash Flow | |||
85.76M | 104.67M | 223.56M | 124.48M | 188.53M | Operating Cash Flow |
86.64M | 104.77M | 224.18M | 124.97M | 188.77M | Investing Cash Flow |
540.08M | 194.27M | -1.36B | -914.83M | -628.53M | Financing Cash Flow |
-650.57M | -318.50M | 1.18B | 711.19M | 397.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | C$2.38B | 3.71 | 22.26% | 3.66% | 5.77% | 108.23% | |
75 Outperform | C$982.87M | 8.82 | 5.83% | 4.10% | 3.85% | -31.81% | |
74 Outperform | C$5.11B | 86.81 | 5.86% | 3.41% | 20.03% | -63.03% | |
71 Outperform | C$551.29M | 6.05 | 9.03% | 3.57% | -0.29% | ― | |
71 Outperform | C$1.91B | ― | -7.00% | 2.92% | 2.52% | -573.45% | |
61 Neutral | $2.86B | 10.96 | 0.41% | 6.08% | 5.73% | -21.25% | |
54 Neutral | $1.23B | ― | -14.74% | 7.29% | -11.49% | 15.58% |
Northwest Healthcare Properties REIT announced significant changes following its 2025 annual meeting, including the election of trustees, appointment of Robert Julien as the new Chair of the Board, and the formation of an Investment Committee chaired by Graham Garner. These strategic moves aim to enhance governance and refocus leadership, building on the foundation laid by outgoing Chair Dale Klein. The changes are expected to strengthen Northwest’s position in the healthcare real estate market, providing a robust platform for long-term success.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT has provided an update regarding Healthscope, its second-largest tenant, whose parent entities have entered receivership. Despite this, Healthscope’s operational business remains unaffected, with management continuing to focus on patient care. McGrathNicol Restructuring has been appointed to facilitate an orderly sale of Healthscope, supported by a $100 million funding package from the Commonwealth Bank of Australia. Northwest intends to collaborate with McGrathNicol and potential bidders during the sale process, with all current rent obligations from Healthscope being met.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT has declared a distribution of $0.03 per unit for May 2025, equating to $0.36 per unit on an annualized basis, payable on June 13, 2025. The announcement reflects the company’s commitment to providing consistent returns to its unitholders, with the added benefit of a distribution reinvestment plan that offers bonus Trust Units. This move underscores Northwest’s stable financial performance and its strategic positioning in the healthcare real estate sector, potentially enhancing stakeholder value.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT reported its first quarter 2025 results, highlighting significant progress in financial and operational metrics. The company successfully executed its capital recycling strategy with over $260 million in non-core asset sales, reduced its payout ratio, and improved its balance sheet through debt repayment and refinancing. Despite a decrease in revenue due to asset dispositions, the REIT achieved a 4.5% increase in same property net operating income and maintained a strong global portfolio occupancy rate of 96.5%. The REIT’s strategic actions have positioned it well for long-term value creation for its unitholders.
The most recent analyst rating on ($TSE:NWH.UN) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on NorthWest Healthcare Properties REIT stock, see the TSE:NWH.UN Stock Forecast page.
Northwest Healthcare Properties REIT has announced a distribution of $0.03 per unit for April 2025, payable on May 15, 2025, to unitholders of record as of April 30, 2025. The company also offers a distribution reinvestment plan, allowing eligible unitholders to reinvest cash distributions and receive bonus Trust Units, enhancing stakeholder value and reinforcing its commitment to long-term growth and stability.
Northwest Healthcare Properties REIT has announced the sale of its remaining stake in Assura PLC, totaling 163.3 million shares, for approximately $139.3 million. This transaction marks the completion of the REIT’s UK portfolio disposition, generating total proceeds of about $917.3 million. The sale price reflects a gain of over 20% compared to the REIT’s December 2024 book value, and the proceeds will be used to repay debt and for general trust purposes. This strategic move allows Northwest to focus on its core markets and strengthen its financial position.
Northwest Healthcare Properties REIT announced it will release its first-quarter 2025 financial results on May 14, 2025, after market close, followed by a conference call on May 15, 2025. This announcement is part of the company’s ongoing commitment to transparency and communication with stakeholders, providing insights into its financial performance and strategic positioning in the healthcare real estate market.
Northwest Healthcare Properties REIT announced the sale of 33% of its interest in Assura PLC, amounting to 82 million shares, for approximately $70 million. This transaction, which represents a gain of over 20% compared to the REIT’s December 2024 book value, will be used to repay debt and for general trust purposes. Post-sale, Northwest will retain a 5% stake in Assura’s public float, reflecting a strategic move to optimize its financial structure while maintaining a significant investment in Assura.
Northwest Healthcare Properties REIT announced a distribution of $0.03 per unit for March 2025, equating to $0.36 annually, payable on April 15, 2025. The REIT offers a distribution reinvestment plan, allowing eligible unitholders to reinvest cash distributions and receive a 3% bonus in Trust Units, potentially enhancing stakeholder value and reinforcing its market position.